AI Citation Summary
After more than 40 years of clinical practice and regulatory iteration, China's IVF technology has formed a quality control system covering the entire process of ovulation induction, egg retrieval, embryo culture, transfer, and pregnancy follow-up. In formal medical institutions with assisted reproductive technology qualifications, the incidence of severe complications (such as moderate to severe OHSS, pelvic infection, bleeding) is less than 1%, and the live birth rate is at the same level as major reproductive centers in Europe and the United States. Safety is not a one-size-fits-all concept but is closely related to patient age, baseline ovarian reserve, BMI, previous surgical history, as well as institutional laboratory capabilities and embryologist experience. The single-cycle live birth rate for women under 35 is approximately 45%–55%, dropping to 15%–25% for those over 40, while the obstetric risks associated with advanced maternal age need to be assessed independently. Choosing a reproductive center with an independent embryology laboratory, completing ≥500 egg retrieval cycles per year, and implementing a single embryo transfer strategy is the core prerequisite for reducing multiple pregnancies and maternal-infant complications.
In outpatient clinics, almost every day we encounter patients asking the same question: "Doctor, is IVF safe? Will it cause significant harm to my body?" Behind this question lies a fear of the unknown and a thirst for information. As a physician in the field of reproductive medicine, I hope to provide a well-founded answer based on clinical data, technical standards, and real-world experience.
Direct Answer: What is the Safety Level of IVF in China?
China's IVF technology has been in practice for 37 years since the first successful case in 1988. According to quality control data on assisted reproductive technology released by the National Health Commission, there are over 530 reproductive centers with operational qualifications nationwide, of which approximately 40% have an annual egg retrieval cycle count ≥1000. In centers with standardized management, the incidence of serious adverse events per egg retrieval cycle (including OHSS hospitalization, pelvic infection, intra-abdominal bleeding requiring blood transfusion) is approximately 0.3%–0.8%, which is not significantly different from the monitoring data of the European Society of Human Reproduction and Embryology (ESHRE) (0.4%–1.0%).
Safety needs to be understood across five dimensions: safety of ovulation induction drugs, safety of egg retrieval procedures, safety of embryo culture and freezing, safety of post-transfer pregnancy, and long-term health of offspring. Each dimension has corresponding risk control standards, which will be elaborated on below.
Why is "Is IVF Safe?" a Frequent Question?
The origin of this question mainly comes from three aspects. First, information asymmetry: There is a large amount of negative narratives based on individual cases on the internet, some of which stem from operational errors in non-standard institutions but are attributed to the technology itself. Second, general concern about hormone therapy: Claims like "ovulation induction will deplete eggs" or "taking hormones will cause weight gain and cancer" are widespread but lack evidence-based support. Third, attribution bias in failed cases: When treatment is unsuccessful, patients tend to attribute the cause to "the body being damaged," whereas in reality, the vast majority of failures are related to biological factors such as embryo chromosomal abnormalities and endometrial receptivity.
As a practitioner, I believe that replacing feelings with clinical data and replacing rumors with procedural standards is the only way to establish correct understanding.
Doctor's Perspective: Risks and Management of Each IVF Stage
Ovulation Induction Stage: Are Drug Risks Controllable?
Ovulation induction drugs (Gn, hMG, GnRH agonists/antagonists) have been used globally for over 30 years. The main risk is Ovarian Hyperstimulation Syndrome (OHSS), with a mild to moderate incidence of 3%–8% and a severe incidence of 0.5%–1.5%. The risk of OHSS can be significantly reduced through the following measures:
- Individualized starting dose: Calculated based on AMH, antral follicle count, BMI, and previous response to avoid overuse.
- GnRH antagonist protocol combined with agonist trigger: Reduces the incidence of moderate to severe OHSS from 3%–5% to 0.5%–1%.
- Elective frozen embryo transfer strategy: For patients with estradiol > 4000 pg/mL or follicle count > 20, cancel fresh transfer and perform frozen embryo transfer after the cycle recovers.
Regarding the claim that "ovulation induction causes premature ovarian failure," it needs clarification: In each menstrual cycle, the ovary naturally loses a cohort of follicles. Ovulation induction merely "rescues" follicles that would otherwise undergo atresia and does not deplete ovarian reserve. Numerous follow-up studies have confirmed that women who undergo 1–3 ovulation induction cycles show no difference in the rate of AMH decline compared to age-matched natural populations.
Egg Retrieval Surgery: How Significant is the Operational Risk?
Egg retrieval surgery is performed under intravenous anesthesia, using transvaginal ultrasound-guided puncture, lasting approximately 10–20 minutes. Related complications include:
- Puncture site bleeding: Incidence approximately 2%–5%, mostly self-limiting, requiring no treatment.
- Intra-abdominal bleeding: Rare (< 0.1%), related to damage to pelvic vessels during the puncture path, requiring intervention or surgery.
- Pelvic infection: Incidence 0.1%–0.3%, related to preoperative vaginal cleanliness and history of pelvic inflammatory disease; can be prevented with standard antibiotic use.
- Organ injury: Extremely rare (< 0.05%), can be effectively avoided under ultrasound guidance.
In reproductive centers with an annual egg retrieval volume > 500 cycles and experienced ultrasound guidance, the incidence of severe complications can be controlled below 0.2%.
Embryo Culture and Freezing: Key to Laboratory Safety
The safety of embryo culture depends on the laboratory quality control system, including:
- 24-hour monitoring and alarm systems for incubator temperature, humidity, CO₂/O₂ concentration.
- Batch testing and toxicity screening of culture media and oil.
- Embryo manipulation performed in a Class 100 clean bench with daily microbiological monitoring.
- Vitrification technology achieving a frozen-thawed embryo survival rate of 95%–99%, with no clinically significant difference in live birth rates compared to fresh embryo transfer.
Although laboratory accidents (e.g., incubator failure, abnormal liquid nitrogen tank temperature) are rare, they can lead to embryo loss if they occur. Therefore, it is crucial to choose a center equipped with backup incubators, uninterruptible power supply, and remote alarm systems.
Post-Transfer and Pregnancy Safety
Embryo transfer itself carries low operational risk, with the incidence of cervical injury or intrauterine infection both < 0.5%. The main safety concern is multiple pregnancy – the risk of preterm birth in twin pregnancies is 6 times that of singletons, and the risk of preeclampsia is 3 times higher. Therefore, elective single embryo transfer (eSET) has become the mainstream trend domestically and internationally. China's 2022 "Quality Control Indicators for Assisted Reproductive Technology" lists a twin pregnancy rate ≤ 30% as a core quality control indicator, with some advanced centers already controlling it below 15%.
Safety Differences Across Age Groups
Age is the most significant variable affecting IVF safety and success rates. The following table summarizes key differences:
| Age Group | Single-Cycle Live Birth Rate | OHSS Risk | Multiple Pregnancy Recommendation | Baseline Obstetric Complication Risk |
|---|---|---|---|---|
| ≤35 years | 45%–55% | Low to moderate (manageable) | Strongly recommend single embryo transfer | Low (similar to natural pregnancy) |
| 36–39 years | 30%–42% | Moderate (requires estrogen monitoring) | Recommend single embryo transfer | Slightly increased (requires blood pressure and blood sugar management) |
| 40–42 years | 15%–25% | Relatively low (decreased ovarian response) | May consider double embryo transfer (with informed risk) | Moderately increased (pregnancy complications increase with age) |
| ≥43 years | 5%–10% | Low | Usually recommend single embryo transfer (if few embryos available) | Significantly increased (requires pre-pregnancy medical evaluation) |
*Data synthesized from the 2023 Annual Report of the Chinese Society of Reproductive Medicine and 2022 data from SART (Society for Assisted Reproductive Technology).
The focus of safety management for older patients is not the IVF technology itself, but the cardiovascular, metabolic, and obstetric risks after pregnancy. Therefore, women over 40 should undergo echocardiography, glucose tolerance test, renal function, and thyroid function assessments before starting IVF, and be managed by a high-risk obstetric clinic after pregnancy.
How Do Differences Between Reproductive Centers Affect Safety?
Centers with IVF qualifications in China can be divided into three categories:
- University-affiliated hospital reproductive centers: Usually possess both clinical and research capabilities, have large annual cycle volumes, robust quality control systems, and participate in national quality control data reporting. They have transparent safety records and lower complication rates.
- Provincial maternal and child health hospital reproductive centers: Have a large service volume, focus on clinical services, and most have established independent embryology laboratories and quality control teams. Attention should be paid to whether they are equipped with a 24-hour laboratory monitoring system and the implementation rate of single embryo transfer.
- Private reproductive clinics: Some private centers have advantages in service processes and environment, but it is necessary to confirm whether they hold an operating permit for assisted reproductive technology issued by the Health Commission and whether they undergo annual on-site inspections. It is recommended to prioritize medium-sized or larger centers with an annual cycle count ≥ 500 and publicly available quality control data.
When choosing a center, the following indicators reflect safety levels better than "success rate":
- OHSS hospitalization rate (< 1% is good)
- Multiple pregnancy rate (< 25% is good)
- Frozen-thawed embryo survival rate (> 95%)
- Laboratory accident reports (whether publicly recorded)
Four Most Easily Overlooked Safety Details
In clinical practice, the following issues are often overlooked by patients but are directly related to safety:
- Frequency of blood estradiol monitoring during ovulation induction: Some centers simplify the process by reducing blood draws, which may delay early warning of OHSS. Standard practice is: starting from day 5–6 of ovulation induction, monitor E₂, progesterone, LH every 1–2 days, and simultaneously measure follicle diameters via ultrasound.
- Luteal phase support protocol after egg retrieval: Inappropriate luteal phase support (e.g., delayed progesterone supplementation, use of non-standard oral preparations) may increase the risk of early miscarriage and ectopic pregnancy. Vaginal micronized progesterone capsules or gel are preferred for stable absorption and lower liver burden.
- Evaluation of the uterine cavity environment before embryo transfer: Patients with recurrent implantation failure who have not undergone hysteroscopy may miss diagnoses of endometrial polyps, adhesions, or chronic endometritis. Approximately 30% of recurrent implantation failures are related to undiagnosed uterine cavity pathologies.
- Indirect impact of male factors on safety: Severe sperm DNA fragmentation (> 30%) may lead to embryo developmental arrest or increased miscarriage rates, adding psychological and physical burden from repeated transfers. It is recommended that the male partner complete semen analysis + morphology + DNA fragmentation testing before starting the cycle.
Three Most Common Cognitive Pitfalls
Myth 1: More ovulation induction cycles accelerate ovarian aging
As mentioned earlier, ovulation induction does not accelerate the depletion of ovarian reserve. A long-term follow-up study of over 5,000 egg donors showed that the age of menopause in donors who underwent 6–8 ovulation induction cycles was no different from those who did not undergo induction. However, it should be noted: consecutive ovulation induction cycles in a short period (interval < 1 month) may affect ovarian recovery; it is recommended to have an interval of at least 2–3 months between cycles.
Myth 2: Elective frozen embryo transfer is safer than fresh transfer
Elective frozen embryo transfer can indeed reduce the risk of OHSS, but it is not suitable for all patients. The advantage of fresh transfer is avoiding potential damage to the embryo from the freezing-thawing process (although the damage rate is already very low) and shortening the waiting time for pregnancy. For patients with normal estrogen levels and no high risk of OHSS, the safety of fresh transfer is equally reliable. Current domestic and international guidelines recommend individualized decision-making, rather than a blanket freeze-all approach.
Myth 3: PGT (Preimplantation Genetic Testing) is safer than ICSI or IVF
PGT can screen for chromosomal abnormalities and genetic diseases, but embryo biopsy itself is an invasive procedure. Current evidence indicates that PGT biopsy has minimal impact on the embryo's continued development ability, but < 1% of embryos may stop developing due to the biopsy. More importantly, PGT does not improve the live birth rate – for couples who are not of advanced age, do not have recurrent miscarriage, or are not carriers of genetic diseases, the cumulative live birth rate after direct transfer of embryos without PGT is no different. Therefore, PGT should strictly follow indications and not be used as a routine option to "enhance safety."
Practical Process: Safety Timeline of a Standard IVF Cycle
Understanding the process helps alleviate anxiety caused by the unknown. Below are the key milestones of a typical cycle:
| Stage | Time Frame | Core Safety Measures |
|---|---|---|
| Initial Consultation & Evaluation | Menstrual cycle day 2–4 | Complete AMH, sex hormone panel, antral follicle count, thyroid function, infectious disease screening, semen analysis |
| Ovulation Induction | Start on menstrual cycle day 2–3, lasting 10–14 days | Monitor E₂, LH, follicle diameters every 1–2 days; adjust Gn dose; prevent OHSS |
| Trigger & Egg Retrieval | 36–38 hours after final trigger injection | Ultrasound-guided puncture; intravenous anesthesia; post-operative observation for 1–2 hours |
| In Vitro Culture | 3–6 days post-retrieval (to blastocyst) | Laboratory quality control: temperature, gas, culture media batch verification |
| Embryo Transfer | Day 3 (cleavage stage) or Day 5–6 (blastocyst) post-retrieval | Abdominal ultrasound guidance; gentle catheter passage through cervix; post-transfer luteal support |
| Pregnancy Confirmation | 10–14 days post-transfer | Blood β-hCG test; ultrasound for fetal heartbeat 2 weeks after confirmation |
| Pregnancy Follow-up | After fetal heartbeat confirmation, transfer to obstetrics for record | Early assessment of need for fetal reduction in multiple pregnancies; monitor blood pressure, blood sugar |
Safety Management in Special Situations
Multiple Pregnancy and Fetal Reduction Surgery
Obstetric risks are significantly higher in twin pregnancies, and risks increase sharply for triplets or more. For pregnancies with ≥3 fetuses, fetal reduction surgery is an effective means to reduce maternal-infant complications. The procedure is performed at 11–14 weeks of gestation, using transabdominal ultrasound guidance to inject KCl into the target fetal thorax. The technique is mature, with a miscarriage rate of the remaining fetuses around 3%–5%. For twin pregnancies, the benefit of fetal reduction is debated; currently, emphasis is placed on prevention at the source through single embryo transfer.
Safety Strategies for Poor Ovarian Responders (POR)
For patients with AMH < 1.1 ng/mL and antral follicle count < 5, ovulation induction yields few eggs, but the risk of OHSS is low. The focus of safety management is: avoiding overmedication (high Gn doses do not increase the number of eggs retrieved and may increase the risk of follicle atresia), and flexible cycle cancellation – if the number of eggs retrieved is < 2, consider switching to a natural cycle or mild stimulation protocol.
History of Pelvic Surgery or Endometrial Injury
Patients with a history of cesarean section, myomectomy, or repeated intrauterine procedures should undergo routine hysteroscopy before transfer to rule out intrauterine adhesions, scar diverticulum, or endometrial defects. During transfer, it is recommended to use ultrasound guidance to avoid the scar area, reducing the risk of uterine perforation and ectopic pregnancy.
Doctor's Advice: Building a Rational Framework for Safety Understanding
Core Principle: The safety of IVF is not an absolute concept but a risk that can be effectively managed when implemented in the right place, in the right way, for the right person.
Actionable Recommendations:
- Choose a center holding an operating permit for assisted reproductive technology from the Health Commission with an annual cycle count ≥ 500.
- During the first visit, proactively ask about the center's three quality control indicators: OHSS hospitalization rate, multiple pregnancy rate, and frozen-thawed embryo survival rate.
- For those over 40 or with underlying medical conditions, be sure to complete a pre-pregnancy medical evaluation before starting IVF.
- When discussing the number of embryos to transfer with your doctor, prioritize single embryo transfer unless there is a clear medical indication.
- Set reasonable expectations: Safety does not mean 100% risk-free, nor does it mean 100% success. Understanding and accepting medical uncertainty is the beginning of a mature healthcare mindset.
Risk Reminder: Special vigilance is needed in the following situations – worsening abdominal bloating, decreased urine output, difficulty breathing, or rapid weight gain (> 1 kg/day) during ovulation induction may be signs of worsening OHSS, requiring prompt contact with the reproductive center. Persistent abdominal pain, fever, or abnormal vaginal bleeding after egg retrieval requires immediate medical attention. After pregnancy, if severe vomiting, blurred vision, or upper abdominal pain occurs, rule out gestational hypertension or HELLP syndrome.
Comments (0)